Cosmos Health Sets Daily Record for US Online Sales

Cosmos Health Inc., a healthcare group listed on Nasdaq, says its sales made directly to consumers in the United States topped $92,000 on October 11, 2026, the highest single-day figure the company has recorded. During the preceding 30 days the channel brought in $902,000, which works out to roughly $30,000 a day. In the most recent ten days the daily average climbed above $60,000, twice the 30-day rate.

What the numbers cover

The figures relate only to the company's own branded web stores in the US. Products sold there include the 18 Series nutraceuticals, the NOOR brand and skincare lines, bought either as one-off orders or on subscription. Cosmos Health links the faster pace to growing brand awareness backed by targeted marketing. If the ten-day rate were to hold for a whole year, it would amount to about $21.9 million in annualized sales. The company had earlier projected annual revenue above $23 million from its US products within 12 to 18 months, and it notes that the present pace is already close to that level.

Why the company favours direct sales

According to Cosmos Health, selling straight to the end customer offers attractive margins and a direct relationship with buyers. It also shows the company how people purchase, information it says can feed into product development and marketing for the rest of its portfolio, and it leaves more control over pricing, presentation and the shopping experience in the company's hands. The US was the first market for this model. The group is now weighing whether to extend it, over time, to other brands it owns and to additional countries.

Chief executive Greg Siokas said the US business is accelerating and that the company intends to keep building on the momentum. He described the country as a strong testing ground: what is learned there about which products sell, how shoppers behave and what leads to repeat orders should carry over to other brands added to the platform. Cosmos Health, incorporated in Nevada in 2009, owns pharmaceutical and nutraceutical brands such as Sky Premium Life and Mediterranation, manufactures in the European Union through its subsidiary Cana Laboratories, and supplies pharmacies and wholesalers through subsidiaries in Greece and the UK. The company cautions that its statements about future sales are forward-looking and subject to risks and uncertainties.

Source: Cosmos Health